These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15306836)

  • 1. Can we reduce hypoglycaemia with insulin detemir?
    Mathieu C
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S35-40. PubMed ID: 15306836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.
    Kølendorf K; Ross GP; Pavlic-Renar I; Perriello G; Philotheou A; Jendle J; Gall MA; Heller SR
    Diabet Med; 2006 Jul; 23(7):729-35. PubMed ID: 16842476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin detemir: improving the predictability of glycaemic control.
    Russell-Jones D
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S29-34. PubMed ID: 15306835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of basal insulins.
    Barnett AH
    Diabet Med; 2003 Nov; 20(11):873-85. PubMed ID: 14632712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin detemir (Levemir)].
    Scheen AJ; Radermecker RP; Philips JC; Paquot N
    Rev Med Liege; 2005 Oct; 60(10):814-9. PubMed ID: 16358671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin detemir: A historical perspective on a modern basal insulin analogue.
    Meneghini L; Liebl A; Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S31-42. PubMed ID: 20394890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin analogues: place of detemir (Levemir)].
    Dorchy H; Sternon J
    J Pharm Belg; 2006; 61(2):58-62. PubMed ID: 16866083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insulins in the treatment of diabetes mellitus.
    Lindholm A
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K; Davies M
    Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
    Owens DR; Bolli GB
    Diabetes Technol Ther; 2008 Oct; 10(5):333-49. PubMed ID: 18715209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin detemir: from concept to clinical experience.
    Home P; Kurtzhals P
    Expert Opin Pharmacother; 2006 Feb; 7(3):325-43. PubMed ID: 16448327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir: a new basal insulin analogue.
    Soran H; Younis N
    Diabetes Obes Metab; 2006 Jan; 8(1):26-30. PubMed ID: 16367879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden.
    Ridderstråle M; Jensen MM; Gjesing RP; Niskanen L
    J Med Econ; 2013; 16(4):468-78. PubMed ID: 23384160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.